BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26266831)

  • 1. The T-Box factor TBX3 is important in S-phase and is regulated by c-Myc and cyclin A-CDK2.
    Willmer T; Peres J; Mowla S; Abrahams A; Prince S
    Cell Cycle; 2015; 14(19):3173-83. PubMed ID: 26266831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TBX3, the gene mutated in ulnar-mammary syndrome, promotes growth of mammary epithelial cells via repression of p19ARF, independently of p53.
    Platonova N; Scotti M; Babich P; Bertoli G; Mento E; Meneghini V; Egeo A; Zucchi I; Merlo GR
    Cell Tissue Res; 2007 May; 328(2):301-16. PubMed ID: 17265068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle.
    Oakes V; Wang W; Harrington B; Lee WJ; Beamish H; Chia KM; Pinder A; Goto H; Inagaki M; Pavey S; Gabrielli B
    Cell Cycle; 2014; 13(20):3302-11. PubMed ID: 25485510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression.
    Baydoun HH; Pancewicz J; Bai X; Nicot C
    Mol Cancer; 2010 Nov; 9():302. PubMed ID: 21092281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual regulation of the anaphase promoting complex in human cells by cyclin A-Cdk2 and cyclin A-Cdk1 complexes.
    Mitra J; Enders GH; Azizkhan-Clifford J; Lengel KL
    Cell Cycle; 2006 Mar; 5(6):661-6. PubMed ID: 16582612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UV-mediated regulation of the anti-senescence factor Tbx2.
    Abrahams A; Mowla S; Parker MI; Goding CR; Prince S
    J Biol Chem; 2008 Jan; 283(4):2223-30. PubMed ID: 18025091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation.
    Carlson H; Ota S; Song Y; Chen Y; Hurlin PJ
    Oncogene; 2002 May; 21(24):3827-35. PubMed ID: 12032820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2.
    Du WW; Yang W; Liu E; Yang Z; Dhaliwal P; Yang BB
    Nucleic Acids Res; 2016 Apr; 44(6):2846-58. PubMed ID: 26861625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The T-Box transcription factor 3 in development and cancer.
    Willmer T; Cooper A; Peres J; Omar R; Prince S
    Biosci Trends; 2017 Jul; 11(3):254-266. PubMed ID: 28579578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
    Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
    Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles and regulation of TBX3 in development and disease.
    Khan SF; Damerell V; Omar R; Du Toit M; Khan M; Maranyane HM; Mlaza M; Bleloch J; Bellis C; Sahm BDB; Peres J; ArulJothi KN; Prince S
    Gene; 2020 Feb; 726():144223. PubMed ID: 31669645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TBX3 over-expression causes mammary gland hyperplasia and increases mammary stem-like cells in an inducible transgenic mouse model.
    Liu J; Esmailpour T; Shang X; Gulsen G; Liu A; Huang T
    BMC Dev Biol; 2011 Oct; 11():65. PubMed ID: 22039763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COL1A2 is a TBX3 target that mediates its impact on fibrosarcoma and chondrosarcoma cell migration.
    Omar R; Cooper A; Maranyane HM; Zerbini L; Prince S
    Cancer Lett; 2019 Sep; 459():227-239. PubMed ID: 31202624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Cdk2/Cyclin E complexes is dependent on the origin of replication licensing factor Cdc6 in mammalian cells.
    Lunn CL; Chrivia JC; Baldassare JJ
    Cell Cycle; 2010 Nov; 9(22):4533-41. PubMed ID: 21088490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.
    Qi Y; Tu Y; Yang D; Chen Q; Xiao J; Chen Y; Fu J; Xiao X; Zhou Z
    J Cell Physiol; 2007 Jan; 210(1):63-71. PubMed ID: 17013808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ING5 is phosphorylated by CDK2 and controls cell proliferation independently of p53.
    Linzen U; Lilischkis R; Pandithage R; Schilling B; Ullius A; Lüscher-Firzlaff J; Kremmer E; Lüscher B; Vervoorts J
    PLoS One; 2015; 10(4):e0123736. PubMed ID: 25860957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ulnar-mammary syndrome gene, Tbx3, is a direct target of the retinoic acid signaling pathway, which regulates its expression during mouse limb development.
    Ballim RD; Mendelsohn C; Papaioannou VE; Prince S
    Mol Biol Cell; 2012 Jun; 23(12):2362-72. PubMed ID: 22535523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.
    Narayanan R; Adigun AA; Edwards DP; Weigel NL
    Mol Cell Biol; 2005 Jan; 25(1):264-77. PubMed ID: 15601848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3.
    Li J; Ballim D; Rodriguez M; Cui R; Goding CR; Teng H; Prince S
    J Biol Chem; 2014 Dec; 289(51):35633-43. PubMed ID: 25371204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.